LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
VRA
Vera Bradley, Inc.
There isn't enough reported data to score VRA yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VRA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
VRA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
VRA PE Valuation
VRA has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
VRA Forward outlook
There aren't enough analyst estimates for VRA to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over VRA on earnings, with more consistent year-over-year improvement.
VRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.37 | +$3.08 |
| Q2 2026 | -$0.69 | +$2.40 |
| Q1 2026 | -$1.72 | +$0.43 |
| Q4 2025 | -$3.43 | -$2.84 |
| Q3 2025 | -$3.45 | -11600% |
| Q2 2025 | -$3.09 | -2307% |
| Q1 2025 | -$2.15 | -960% |
| Q4 2024 | -$0.59 | +$0.01 |
VRA is still losing money, but far less than before: $0.37 per share over the past year, against $3.45 at its worst in mid-2025.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over VRA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
VRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.6M | +1.1% |
| Q2 2026 | $55.7M | +7.8% |
| Q1 2026 | $84.9M | -15% |
| Q4 2025 | $62.3M | -23% |
| Q3 2025 | $70.9M | -36% |
| Q2 2025 | $51.7M | -36% |
| Q1 2025 | $100M | -25% |
| Q4 2024 | $80.6M | -30% |
VRA's revenue has slid since its 2020 peak: $72M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | -8.3% | +26 points |
| Q1 2026 | 3.2% | +27 points |
| Q4 2025 | -20% | -6.6 points |
| Q3 2025 | -6.5% | -9.1 points |
| Q2 2025 | -35% | -20 points |
| Q1 2025 | -23% | -21 points |
| Q4 2024 | -13% | -19 points |
VRA has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
VRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.3M | +$28.4M |
| Q2 2026 | -$5.6M | +$14.2M |
| Q1 2026 | $17.1M | -1.3% |
| Q4 2025 | -$4.5M | +$20.6M |
| Q3 2025 | -$6.1M | -$4.8M |
| Q2 2025 | -$19.8M | -$4.4M |
| Q1 2025 | $17.3M | -33% |
| Q4 2024 | -$25M | -686% |
VRA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
VRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.7% | +1.9M shares |
| 1 year | +7.4% | +2.1M shares |
| 3 years | -3.6% | -1.1M shares |
| 5 years | -13% | -4.5M shares |
| Available history | -12% | -4.1M shares |
VRA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $585,000 |
| Q4 2024 | $5.3M |
| Q3 2024 | $9.5M |
| Q2 2024 | $6.3M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -14.1x | Net Cash |
| Q2 2024 | -4.2x | Net Cash |
| Q1 2024 | -4.2x | Net Cash |
| Q2 2022 | -2.1x | Net Cash |
| Q1 2022 | -2.4x | Net Cash |
| Q4 2021 | -2.0x | Net Cash |
| Q3 2021 | -1.8x | Net Cash |
| Q2 2021 | -1.1x | Net Cash |
VRA has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
VRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 82.4 | Overbought |
| Stochastic | 89.3 | Overbought |
VRA's weekly RSI is 82 (overbought) and its Stochastic is 89 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
VRA PE vs Consumer Cyclical Sector
| Metric | VRA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
VRA has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
VRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.91 | 28% above |
| 20 week MA | $4.50 | 68% above |
| 50 week MA | $3.67 | 106% above |
| 100 week MA | $3.08 | 145% above |
| 200 week MA | $4.72 | 60% above |
VRA has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
VRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.6 | $8.10 | -30% |
| 2021 | $8.10 | $8.54 | +5.4% |
| 2022 | $8.54 | $4.13 | -52% |
| 2023 | $4.13 | $7.70 | +86% |
| 2024 | $7.70 | $3.60 | -53% |
| 2025 | $3.60 | $2.28 | -37% |
| 2026 YTD | $2.28 | $7.56 | +232% |
VRA has the edge over LCID on returns for 2026, with the stronger performance.